Parasite antibiotic resistance and mosquito insecticide resistance has increased the need for the development of malaria vaccines to combat the spread of the disease. The long term goal of this project is the development of a vaccine against P. falciparum malaria and the development of a strategy for producing vaccines against other malaria species. The method is to identify parasite antigens that can induce antimalarial antibodies with a capacity to inhibit the blood stage cycle of the parasite. Antigens will be identified by producing mouse/mouse and human/human hybridomas using lymphocytes from immune mice and humans. These hybridomas will be a source of growth inhibitory-antimalarial monoclonal antibodies that will be used as probes to initially identify and isolate antigens that may be used to produce an antimalarial vaccine. Polyclonal antibody produced by the antigen initially purified with monoclonal antibody will be used to obtain sufficient antigen for further specific antigen studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022038-02
Application #
3132644
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1985-06-01
Project End
1988-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755